Silicon Valley-based healthcare AI business Enlitic is understood to be preparing for a run at the ASX boards, after scoring investment from Regal Funds Management and Alex Waislitz’s Thorney companies in past capital-raising rounds.
Enlitic aims to streamline data workflows for radiologists and other medical professionals.
Street Talk understands Enlitic management has met with Barrenjoey, Shaw and Partners, MST Financial, Bell Potter, Canaccord and Morgans in recent weeks to select a broker line-up for its sharemarket float.
It’s early days, but Enlitic is expected to raise about $40 million for a $300 million-odd market capitalisation. MST Financial is understood to be well-placed to get a gig, given the broker’s well-regarded health/technology analysts Lafitani Sotiriou and Andrew Goodsall. At least one other broker is expected to be appointed.
The nine-year-old business’s choice of Australia as its listing destination may stem from its founder Jeremy Howard’s Australian background, as well as its chief executive Michael Sistenich’s experience locally. Sistenich founded Sydney boutique advisory firm Aurenda Partnersand previously worked at Bell Potter.
Add to My Watchlist
What is My Watchlist?